Trupanion (TRUP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 revenue grew 15% year-over-year to $327.5 million, with subscription revenue up 20% and other business up 5%.
Net income was $1.4 million, reversing a $4.0 million loss in Q3 2023; nine-month net loss narrowed to $11.3 million from $42.5 million.
Subscription-adjusted operating income grew 66% year-over-year, with a margin of 14%, the highest since Q1 2022, driven by pricing actions and operational discipline.
Pet acquisition spend increased, enrolling 65,800 new pets with a 36% IRR; total subscription pets rose 6% to over 1,032,000.
Free cash flow for Q3 2024 was $13.4 million, with trailing 12-month free cash flow reaching $30 million.
Financial highlights
Total revenue: $327.5 million for Q3 2024 (+15%); subscription revenue: $219.0 million (+20%).
Net income: $1.4 million ($0.03 per share) for Q3 2024, compared to a net loss of $4.0 million last year.
Adjusted operating income: $32.6 million, up 37% year-over-year; adjusted EBITDA: $14.5 million, up from $6.1 million.
Free cash flow: $13.4 million for Q3 2024, a $6.4 million improvement year-over-year.
Cash and short-term investments: $293.1 million at quarter end.
Outlook and guidance
Full-year revenue guidance raised to $1.281–$1.286 billion, representing 16% growth at midpoint.
Subscription revenue expected at $856–$858 million, up 20% year-over-year.
Adjusted operating income guidance increased to $114–$117 million, up 38% year-over-year.
Q4 revenue expected at $333–$338 million; subscription revenue at $227–$229 million.
Management expects continued enrollment and revenue growth, leveraging strong free cash flow and improved profitability.
Latest events from Trupanion
- Strong growth, data-driven innovation, and new products position the company for market expansion.TRUP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Low market penetration and strong recurring revenue signal major growth potential.TRUP
Investor presentation2 Mar 2026 - 2026 guidance highlights pricing-led growth, margin expansion, and broader customer acquisition.TRUP
BofA Securities Animal Health Summit26 Feb 2026 - Revenue up 12% to $1.44B, net income $19.4M, strong cash flow and subscription growth.TRUP
Q4 202512 Feb 2026 - Q2 2024 revenue up 16%, margins and cash flow improved, and pet retention remained strong.TRUP
Q2 20242 Feb 2026 - Margin expansion, strong retention, and capital surplus drive disciplined growth and innovation.TRUP
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Sustainable growth driven by vet channel, margin recovery, and international expansion.TRUP
Investor Day 202420 Jan 2026 - Q1 2025 saw 12% revenue growth, higher margins, and improved retention with raised guidance.TRUP
Q1 202526 Dec 2025 - 2025 will see renewed marketing investment, high retention, and continued tech-driven growth.TRUP
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202523 Dec 2025